IVX only have rights to Asia Pacific not including China but are funding trials that I presume would be accepted everywhere e.g. the big markets of the USA & Europe. Do IVX get anything back for this external benefit they will be providing?
Do they / will they have any 100% owned IP associted with these therapies that they can earn from globaly?
Even in the restricted market, it looks like a great story, especially at these prices. It is going to be interesting to see how it gos as trials get underway and especialy when they are successful, which seems a likely outcome form the interviews description of the work to date in animal models etc.
It woul be nce to see my 3 million oppies at 33 cents before exercise date - we can only dream!
IVX Price at posting:
1.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)